Donate

This World Cancer Day, SAHMRI reflects with pride and ambition on our ongoing efforts to improve the lives of people around the world who live with cancer.

The meaningful contributions we have made to cancer research and health care would not have been possible without working alongside our many partners including the public and private health systems, universities, fellow medical research institutes, funding and advocacy partners and government departments. The importance of these partnerships grows by the day and is clearly evident when seeing the incredible array of recent advancements in cancer prevention, diagnosis, treatment and care.

At SAHMRI, the breadth of our Cancer research program has grown to the point where we have now created distinct programs for Blood Cancers and Solid Tumours.

While our programs foci include acute lymphoblastic leukaemia, chronic myeloid leukaemia, myeloma and prostate and gastrointestinal cancers; our researchers’ work spans numerous other cancer-related diseases and many of their discoveries are applied across the cancer spectrum.

SAHMRI and our partners are also at the forefront of bringing the latest cancer treatment to Australians living with the disease, as we develop the nation’s first proton therapy treatment unit. Proton therapy is a precise, non-invasive form of radiotherapy than destroy cancer cells while minimising damage to surrounding health tissue including vital organs.

The Australian Bragg Centre for Proton Therapy and Research, under construction next to SAHMRI’s headquarters in Adelaide BioMed City, will treat around 600 patients each year, but also be home to a cutting-edge research program that will unlock further potential of this still relatively novel cancer treatment technology.

The Australian Bragg Centre building is on track for completion in 2023, with treatments to begin 12-18 months later following the installation and testing of the proton therapy unit.